Patients
17.6 % of people
People aged 65 and over, New Zealand, 2025 (World Bank).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Vidhi Upadhyay
New Zealand Hyperbaric Oxygen Therapy Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$29.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $42.4 Mn | — | — |
| 2025 (base) | $44.8 Mn | +$2.4 Mn | — |
| 2026 (forecast) | $47.4 Mn | +$2.6 Mn | +5.7% |
| 2027 (forecast) | $50.1 Mn | +$2.7 Mn | +11.7% |
| 2028 (forecast) | $52.9 Mn | +$2.9 Mn | +18.1% |
| 2029 (forecast) | $55.9 Mn | +$3.0 Mn | +24.8% |
| 2030 (forecast) | $59.1 Mn | +$3.2 Mn | +31.9% |
| 2031 (forecast) | $62.5 Mn | +$3.4 Mn | +39.5% |
| 2032 (forecast) | $66.0 Mn | +$3.6 Mn | +47.4% |
| 2033 (forecast) | $69.8 Mn | +$3.8 Mn | +55.8% |
| 2034 (forecast) | $73.8 Mn | +$4.0 Mn | +64.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $44.8 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $73.8 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, application and end user (see all) |
| Key players | Sechrist Industries, Perry Baromedical, Oxy Health, Fink Engineering, ETC BioMedical Systems (see all) |
| Regulator in New Zealand | Medsafe (WAND)Source: Medsafe. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Hyperbaric oxygen therapy has patients breathe pure oxygen in a pressurised chamber to help wounds heal and treat certain conditions.
Key segments of the hyperbaric Oxygen Therapy market include product (Monoplace Chambers, Multiplace Chambers and Portable Chambers) and application (Wound Healing, Decompression Sickness and Wellness and Longevity).
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the hyperbaric Oxygen Therapy market. Older adults and their families are spending more on staying active and independent.
Preventive care, personalised plans based on biomarkers and home-based services give the hyperbaric Oxygen Therapy market room to grow, especially in fast-ageing countries in Asia and Europe.
Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the hyperbaric Oxygen Therapy market.
The hyperbaric Oxygen Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe.[1] Pharmac decides which medicines and medical devices the public health system pays for.[2] People aged 65 and over: 17.6% of people in 2025, the latest World Bank figure for New Zealand.[3]
[1] Medsafe. Checked 14 Nov 2026.
[2] Pharmac. Checked 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hyperbaric Oxygen Therapy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in New Zealand.
What doctors and scientists are doing in Hyperbaric Oxygen Therapy right now, from free public sources.
17.6 % of people
People aged 65 and over, New Zealand, 2025 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.
From our blog
New Zealand
New Zealand
New Zealand
New Zealand
New Zealand
New Zealand
Pharmaceuticals · New Zealand
Healthcare Services · New Zealand
Pharmaceuticals · New Zealand
Pharmaceuticals · New Zealand
Healthcare Services · New Zealand
Healthcare Services · New Zealand